BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22306041)

  • 1. In vitro sustained release of bioactive anti-NogoA, a molecule in clinical development for treatment of spinal cord injury.
    Stanwick JC; Baumann MD; Shoichet MS
    Int J Pharm; 2012 Apr; 426(1-2):284-290. PubMed ID: 22306041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced neurotrophin-3 bioactivity and release from a nanoparticle-loaded composite hydrogel.
    Stanwick JC; Baumann MD; Shoichet MS
    J Control Release; 2012 Jun; 160(3):666-75. PubMed ID: 22510446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal delivery of a polymeric nanocomposite hydrogel after spinal cord injury.
    Baumann MD; Kang CE; Tator CH; Shoichet MS
    Biomaterials; 2010 Oct; 31(30):7631-9. PubMed ID: 20656347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local Delivery of Neurotrophin-3 and Anti-NogoA Promotes Repair After Spinal Cord Injury.
    Elliott Donaghue I; Tator CH; Shoichet MS
    Tissue Eng Part A; 2016 May; 22(9-10):733-41. PubMed ID: 27056081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An injectable drug delivery platform for sustained combination therapy.
    Baumann MD; Kang CE; Stanwick JC; Wang Y; Kim H; Lapitsky Y; Shoichet MS
    J Control Release; 2009 Sep; 138(3):205-13. PubMed ID: 19442692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localized and sustained delivery of fibroblast growth factor-2 from a nanoparticle-hydrogel composite for treatment of spinal cord injury.
    Kang CE; Baumann MD; Tator CH; Shoichet MS
    Cells Tissues Organs; 2013; 197(1):55-63. PubMed ID: 22796886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization.
    Beck-Broichsitter M; Kleimann P; Gessler T; Seeger W; Kissel T; Schmehl T
    Int J Pharm; 2012 Jan; 422(1-2):398-408. PubMed ID: 22001839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A hydrogel composite system for sustained epi-cortical delivery of Cyclosporin A to the brain for treatment of stroke.
    Caicco MJ; Cooke MJ; Wang Y; Tuladhar A; Morshead CM; Shoichet MS
    J Control Release; 2013 Mar; 166(3):197-202. PubMed ID: 23306024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annealing as a tool for the optimization of lyophilization and ensuring of the stability of protein-loaded PLGA nanoparticles.
    Fonte P; Lino PR; Seabra V; Almeida AJ; Reis S; Sarmento B
    Int J Pharm; 2016 Apr; 503(1-2):163-73. PubMed ID: 26972381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
    He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
    Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An anti-inflammatory peptide and brain-derived neurotrophic factor-modified hyaluronan-methylcellulose hydrogel promotes nerve regeneration in rats with spinal cord injury.
    He Z; Zang H; Zhu L; Huang K; Yi T; Zhang S; Cheng S
    Int J Nanomedicine; 2019; 14():721-732. PubMed ID: 30705588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained dual drug delivery of anti-inhibitory molecules for treatment of spinal cord injury.
    Wilems TS; Sakiyama-Elbert SE
    J Control Release; 2015 Sep; 213():103-111. PubMed ID: 26122130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneously manufactured nano-in-micro (SIMANIM) particles for dry-powder modified-release delivery of antibodies.
    Kaye RS; Purewal TS; Alpar HO
    J Pharm Sci; 2009 Nov; 98(11):4055-68. PubMed ID: 19189420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Kumar PS; Ramakrishna S; Saini TR; Diwan PV
    Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated release of a sparingly soluble drug from an injectable hyaluronan-methylcellulose hydrogel.
    Wang Y; Lapitsky Y; Kang CE; Shoichet MS
    J Control Release; 2009 Dec; 140(3):218-23. PubMed ID: 19470396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of biodegradable films containing the potent osteogenic compound BFB0261 for localized delivery.
    Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S
    Int J Pharm; 2011 Feb; 404(1-2):10-8. PubMed ID: 21047548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined and sequential delivery of bioactive VEGF165 and HGF from poly(trimethylene carbonate) based photo-cross-linked elastomers.
    Chapanian R; Amsden BG
    J Control Release; 2010 Apr; 143(1):53-63. PubMed ID: 19961885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-encapsulation of lyoprotectants improves the stability of protein-loaded PLGA nanoparticles upon lyophilization.
    Fonte P; Araújo F; Seabra V; Reis S; van de Weert M; Sarmento B
    Int J Pharm; 2015 Dec; 496(2):850-62. PubMed ID: 26474964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein bioactivity and polymer orientation is affected by stabilizer incorporation for double-walled microspheres.
    Kokai LE; Tan H; Jhunjhunwala S; Little SR; Frank JW; Marra KG
    J Control Release; 2010 Jan; 141(2):168-76. PubMed ID: 19751780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.